People · Operator
Named in public records as an officer, director or promoter · active 2018–2023 · Other, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ZwitterCo, Inc. | — | Other | Series B | $42.4M | $355.6M | 2018 |
| Xsphera Biosciences Inc | — | Biotechnology | Series A | $12.7M | $117.4M | 2022 |
| Epistemix, Inc. | — | Other Technology | Series A | $11.7M | $30.3M | 2022 |
Stephen Remondi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen Remondi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Pontin | 1 | 5 |
| Adam Lipman | 1 | 4 |
| Benjamin Dahl | 1 | 4 |
| Earl Jones | 1 | 2 |
| ROBERT DELACH | 1 | 2 |
| Robert Walsh | 1 | 2 |
| Alex Rappaport | 1 | 2 |
| H EARL JONES | 1 | 2 |
| GREG EARL FISICHELLI | 1 | 1 |
| John Cordier | 1 | 1 |
| Daniel Litvak | 1 | 1 |
| John Greffenstette | 1 | 1 |
| Donald Burke | 1 | 1 |
| John Grefenstette | 1 | 1 |
| CHRISTOPHER DROVER | 1 | 1 |
| STEVE REMONDI | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.